Stemcentrx

PARTNERED IN 2011

Aquired by AbbVie in 2016 for $10.2 billion

 

INTRODUCTION

ARTIS has spent over a decade backing bold teams who take the hard path; building market-defining companies to re-shape, re-invent, and re-make industries.

 
INSIGHTS